Patents Assigned to Genesis Research & Development Corporation Ltd.
  • Patent number: 7192590
    Abstract: The present invention provides polypeptides comprising an immunogenic epitope of a M. vaccae protein, polynucleotides encoding such polypeptides, and fusion proteins comprising at least one such polypeptide, together with genetic constructs comprising at least one inventive polynucleotide. Compositions comprising such polypeptides, polynucleotides, fusion proteins and/or genetic constructs may be employed in the treatment of infectious diseases and immune disorders.
    Type: Grant
    Filed: June 26, 2003
    Date of Patent: March 20, 2007
    Assignee: Genesis Research and Development Corporation, Ltd.
    Inventor: Alain Delcayre
  • Patent number: 7041295
    Abstract: The present invention provides polypeptides comprising an immunogenic epitope of a M. vaccae protein, polynucleotides encoding such polypeptides, and fusion proteins comprising at least one such polypeptide, together with genetic constructs comprising at least one inventive polynucleotide. Compositions comprising such polypeptides, polynucleotides, fusion proteins and/or genetic constructs may be employed in the treatment of infectious diseases and immune disorders.
    Type: Grant
    Filed: March 14, 2002
    Date of Patent: May 9, 2006
    Assignee: Genesis Research & Development Corporation LTD
    Inventor: Alain Delcayre
  • Publication number: 20050202077
    Abstract: Compositions for the treatment and/or prevention of IgE-mediated disorders in a mammal by means of RNA interference are provided, together with methods for the use of such compounds. The inventive compositions comprise a binding agent that specifically binds to a target internalizable antigen that is expressed on the surface of a target cell of interest and a genetic construct that is capable of expressing a small interfering nucleic acid molecule (siNA) that suppresses expression of a target gene within the target cell, whereby, after binding to the target antigen, the binding agent and genetic construct are internalized into the cell, and the genetic construct released.
    Type: Application
    Filed: February 22, 2005
    Publication date: September 15, 2005
    Applicant: GENESIS RESEARCH AND DEVELOPMENT CORPORATION LTD.
    Inventors: James Watson, J. Murison, Murray Grigor, Ilkka Havukkala, Grant Munro, Nevin Abernethy, Gill Webster
  • Publication number: 20030229922
    Abstract: Novel isolated polynucleotides and polypeptides associated with the synthesis of plant cell wall polysaccharides are provided, together with genetic constructs comprising such sequences. Methods for using such constructs for the modulation of polysaccharide content in plants are also disclosed, together with transgenic plants comprising such constructs.
    Type: Application
    Filed: March 20, 2003
    Publication date: December 11, 2003
    Applicants: GENESIS RESEARCH AND DEVELOPMENT CORPORATION LTD., RUBICON FORESTS HOLDINGS LIMITED
    Inventor: Leonard N. Bloksberg
  • Patent number: 6476209
    Abstract: Novel polynucleotides isolated from Lactobacillus rhamnosus, as well as probes and primers, genetic constructs comprising the polynucleotides, biological materials, including plants, microorganisms and multicellular organisms incorporating the polynucleotides, polypeptides expressed by the polynucleotides, and methods for using the polynucleotides and polypeptides are disclosed.
    Type: Grant
    Filed: November 28, 2000
    Date of Patent: November 5, 2002
    Assignees: Genesis Research & Development Corporation Ltd., Via Lactia BioScience (NZ) Ltd.
    Inventors: Matthew Glenn, Mark W. Lubbers, James Dekker
  • Patent number: 6410718
    Abstract: Novel isolated polynucleotides and polypeptides associated with the lignin biosynthetic pathway are provided, together with constructs including such sequences. Methods for the modulation of lignin content, lignin structure and lignin composition in target organisms are also disclosed, the methods comprising incorporating one or more of the polynucleotides of the present invention into the genome of a target organism.
    Type: Grant
    Filed: July 12, 2000
    Date of Patent: June 25, 2002
    Assignees: Genesis Research & Development Corporation Ltd., Fletcher Challenge Forests Ltd.
    Inventors: Leonard N. Bloksberg, Ilkka Havukkala
  • Patent number: 6380362
    Abstract: Novel polynucleotides including partial and extended sequences, and open reading frames, are provided, together with probes and primers, DNA constructs comprising the polynucleotides, biological materials and organisms incorporating the polynucleotides, polypeptides expressed by the polynucleotides, and methods for using the polynucleotides and polypeptides.
    Type: Grant
    Filed: November 28, 2000
    Date of Patent: April 30, 2002
    Assignee: Genesis Research & Development Corporation Ltd.
    Inventors: James D. Watson, James G. Murison
  • Patent number: 6380459
    Abstract: Novel isolated plant polynucleotide promoter sequences are provided, together with DNA constructs comprising such polynucleotides. Methods for using such constructs in modulating the transcription of DNA sequences of interest are also disclosed, together with transgenic plants comprising such constructs.
    Type: Grant
    Filed: March 25, 1999
    Date of Patent: April 30, 2002
    Assignees: Genesis Research & Development Corporation Ltd., Fletcher Challenge Forests Ltd.
    Inventors: J. Ranjan Perera, Stephen J. Rice
  • Patent number: 6359198
    Abstract: Novel isolated polynucleotides that encode polypeptides involved in plant cell signaling are provided, together with DNA constructs comprising such polynucleotides. Methods for using such constructs for the modulation of cell signaling in plants are also disclosed, together with transgenic plants comprising such constructs.
    Type: Grant
    Filed: January 12, 1999
    Date of Patent: March 19, 2002
    Assignee: Genesis Research & Development Corporation Ltd.
    Inventors: Timothy J. Strabala, Nicolaas J. Nieuwenhuizen
  • Patent number: 6242419
    Abstract: Isolated polynucleotides encoding polypeptides expressed in mammalian fsn -/- lymph node stromal cells are provided, together with expression vectors and host cells comprising such isolated polynucleotides. In certain embodiments such polynucleotides encode members of the fibroblast growth factor receptor family. Methods for the use of such polynucleotides and polypeptides are also provided.
    Type: Grant
    Filed: August 26, 1999
    Date of Patent: June 5, 2001
    Assignee: Genesis Research & Development Corporation Ltd.
    Inventors: Lorna Strachan, Matthew Sleeman, Nevin Abernethy, Rene Onrust, Anand Kumble, Greg Murison
  • Patent number: 5850020
    Abstract: Novel isolated DNA sequences associated with the lignin biosynthetic pathway are provided, together with DNA constructs including such sequences. Methods for the modulation of lignin content in plants are also disclosed, the methods comprising incorporating one or more of the inventive DNA sequences or a sequence complementary to an inventive DNA sequence into the genome of a plant.
    Type: Grant
    Filed: September 11, 1996
    Date of Patent: December 15, 1998
    Assignees: Genesis Research & Development Corporation, Ltd., Fletcher Challenge Forests Limited
    Inventors: Leonard N. Bloksberg, Ilkka Havukkala, Alastair Grierson